What we do
Corporate Governance Advisory Services
ESG Advisory Services
M&A and Information Agent Services
Capital Market Intelligence Services
Proxy Contests, Hostile Takeovers, Shareholder Activism and Special Situations
Proxy Solicitation and Shareholder Meeting Services
Retail Services and Additional Capabilities
Board of Director Services
Debt Services
SPAC Advisory Services
Services for Registered Funds - Mutual Funds, Exchange Traded Funds (ETFs) and Closed-End Funds - Di Costa Partners
Client Portal

Recent Mergers and Acquisitions

Upjohn spin-off from Pfizer and subsequent merger with Mylan to form Viatris

Pfizer (NYSE: PFE), a multinational pharmaceutical company, completed the spin off of its Upjohn business unit which subsequently combined with Mylan N.V., a European pharmaceutical firm, to form Viatris (Nasdaq: VTRS) in a transaction valued at $12 billion.

Morrow Sodali acted as the information agent for the bidder in this transaction.

Find more information here.

Topics

Upjohn spin-off from Pfizer and subsequent merger with Mylan to form Viatris

Topics

Pfizer (NYSE: PFE), a multinational pharmaceutical company, completed the spin off of its Upjohn business unit which subsequently combined with Mylan N.V., a European pharmaceutical firm, to form Viatris (Nasdaq: VTRS) in a transaction valued at $12 billion.

Morrow Sodali acted as the information agent for the bidder in this transaction.

Find more information here.

© 2016 - 2021 Morrow Sodali